Caloric intake and Alzheimer's disease

Interdisciplinary Topics in Gerontology

Volumn 35, Issue , 2007, Pages 159-175

  Pasinetti, G ^a   Zhao, Z ^b   Qin, W ^b   Ho, L ^b   Shrishailam, Y ^b   MacGrogan, D ^b   Ressmann, W ^b   Humala, N ^b   Liu, X ^b   Romero, C ^b   Stetka, B ^b   Chen, L ^b   Ksiezak Reding, H ^b   Wang, J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CALORIC RESTRICTION; DISEASE COURSE; HUMAN; LIFESTYLE; METABOLISM; ONSET AGE; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

AGE OF ONSET; ALZHEIMER DISEASE; CALORIC RESTRICTION; DISEASE PROGRESSION; HUMANS; LIFE STYLE; RISK ASSESSMENT; RISK FACTORS;

EID: 38549146929     PISSN: 00741132     EISSN: 16623800     Source Type: Book Series    
DOI: 10.1159/000096561     Document Type: Review

References (60)

1. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M: Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross-sectional population based study. BMJ 1997;315:1045-1049.
2. Franco KS, Bronson D: Diabetes mellitus and Alzheimer's disease. Arch Neurol 2005;62:330.
3. Luchsinger JA, Tang MX, Shea S, Mayeux R: Hyperinsulinemia and risk of Alzheimer's disease. Neurology 2004;63:1187-1192.
4. Luchsinger JA, Mayeux R: Dietary factors and Alzheimer's disease. Lancet Neurol 2004;3:579-587.
5. Craft S, Watson GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178.
6. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM: Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 2004;18:902-904.
7. Ristow M: Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004;82:510-529.
8. Luchsinger JA, Tang MX, Shea S, Mayeux R: Caloric intake and the risk of Alzheimer's disease. Arch Neurol 2002;59:1258-1263.
9. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I: An 18-year follow-up of overweight and risk of Alzheimer's disease. Arch Intern Med 2003;163:1524-1528.
10. Sriram K, Benkovic SA, Miller DB, O'Callaghan JP: Obesity exacerbates chemically induced neurodegeneration. Neuroscience 2002;115:1335-1346.
11. Mattson MP: Will caloric restriction and folate protect against AD and PD? Neurology 2003;60:690-695.
12. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM: Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 2005;19:659-661.
13. Patel NV, Gordon MN, Connor KE, Good RA, Engelman RW, Mason J, Morgan DG, Morgan TE, Finch CE: Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models. Neurobiol Aging 2005;26:995-1000.
14. Maswood N, Young J, Tilmont E, Zhang Z, Gash DM, Gerhardt GA, Grondin R, Roth GS, Mattison J, Lane MA, Carson RE, Cohen RM, Mouton PR, Quigley C, Mattson MP, Ingram DK: Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci USA 2004;101:18171-18176.
15. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr, Frautschy SA, Cole GM: A diet enriched with omega-3 fatty acid docosahexaenoic acid reduces amyloid brain burden in an aged Alzheimer mouse model. J Neurosci 2005;25:3032-3040.
16. Puri BK, Leavitt BR, Hayden MR, Ross CA, Rosenblatt A, Greenamyre JT, Hersch S, Vaddadi KS, Sword A, Horrobin DF, Manku M, Murck K: Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology 2005;65:286-292.
17. Cummings JL: Alzheimer's disease. N Engl J Med 2004;351:56-67.
18. Brookmeyer R, Gray S, Kawas S: Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
19. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
20. Katz DA, McHorney CA, Atkinson RL: Impact of obesity on health-related quality of life in patients with chronic illness. J Gen Intern Med 2000;15:789-796.
21. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP: The spread of obesity epidemic in the United States, 1991-1998. JAMA 1994;282:1519-1522.
22. Flegal KM, Troiano RP: Changes in the distribution of body mass index of adults and children in the US population. Int J Obes Relat Metab Disord 2000;24:807-818.
23. Flegal KM, Troiano RP, Ballard-Barbash R: Aim for a healthy weight: what is the target? J Nutr 2001;131:440S-450S.
24. Auwerx J, Staels B: Leptin. Lancet 1998;351:737-742.
25. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K: Obesity in middle age and future risk of dementia: a 27-year longitudinal population based study. BMJ 2005;330:1360.
26. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ: Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS, Honolulu-Asia Aging Study. Neurobiol Aging 2000;21:57-62.
27. Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer's disease. Alzheimer Dis Assoc Disord 1999;13:S106-114.
28. Seshadri S, Wolf PA: Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol 2003;2:11.
29. Hu FB, Willet WC: Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-2578.
30. Bray GA, Lovejoy JC, Smith SR, DeLany JP, Lefevre M, Hwang D, Ryan DH, York DA: The influence of different fats and fatty acids on obesity, insulin resistance, and inflammation. J Nutr 2002;132:2488-2491.
31. Cohn JS: Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease. Curr Opin Lipidol 2002;13:19-24.
32. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
33. Sparks DL, Martins R, Martin T: Cholesterol and cognition: rationale for the cholesterol-lowering treatment trial and sex related differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits. Ann NY Acad Sci 2002;977:356-366.
34. Berglund L: The APOE gene and diets - food (and drink) for thought. Am J Clin Nutr 2001;73:669-670.
35. Petot GJ, Traore F, Debanne SM, Lerner AJ, Smyth KA, Friedland RP: Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. Metabolism 2003;52:279-281.
36. Agar E, Demir S, Amanvermez R, Bosnak M, Ayyildiz M, Celik C: The effects of ethanol consumption on the lipid peroxidation and glutathione levels in the right and left brains of rats. Int J Neurosci 2003;113:1643-1652.
37. Mukamal KJ, Longstreth WT Jr, Mittleman MA, Crum RM, Siscovivk DS: Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001;32:1939-1946.
38. Goldberg IJ, Mosca L, Piano MR, Fisher EA: Wine and your heart: a science advisory for healthcare professionals from the nutrition committee, council on epidemiology and prevention, and council on cardiovascular nursing of the American Heart Association. Circulation 2001;103:472-475.
39. Mukamal KJ, Kuller LJ, Fitzpatrick AL, Longstreth WT Jr, Mittleman MA, Siscovick DS: Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003;289:1405-1413.
40. Galanis DJ, Joseph C, Masaki KH, Petrovitch H, Ross GW, White L: A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. Am J Public Health 2000;90:1254-1259.
41. Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW: The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults. Ann Intern Med 2005;142:725-733.
42. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F: A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004;113:1456-1464.
43. Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H: Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001;21:2561-2570.
44. Hoyer S: The aging brain: changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer's disease. J Neural Transm 2002;109:991-1002.
45. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL: Incidence of dementia and Alzheimer's disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001;285:739-747.
46. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S: Insulin-degrading enzyme regulates the levels of insulin, amyloid-β protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162-4167.
47. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL: Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 2003;100:6221-6226.
48. Mattson MP, Chan SL, Duan W: Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 2002;82:637-672.
49. Zhu H, Guo Q, Mattson MP: Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res 1999;842:224-229.
50. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 1996;274:99-102.
51. Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC: A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. Ann Intern Med 2004;140:769-777.
52. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ, Samaha FF: The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Intern Med 2004;140:778-785.
53. Vanhanen M, Soininen H: Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr Opin Neurol 1998;11:673-677.
54. Wang R, Sweeny D, Gandy SE, Sisodia SS: The profile of soluble amyloid β protein in cultured cell media. J Biol Chem 1996;271:31894-31902.
55. Cao SX, Dhahbi JM, Monte PL, Spindler SR: Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA 2001;98:10630-10635.
56. Merry BJ: Oxidative stress and mitochondrial function with aging - the effects of caloric restriction. Aging Cell 2004;3:7-12.
57. Moreira PI, Honda K, Liu Q, Santos MS, Oliveira CR, Aliev G, Nunomura A, Zhu X, Smith MA, Perry G: Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr Alzheimer Res 2005;2:403-408.
58. Rosemuller AJ, van Gool WA, Eikelenboom P: The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications. Curr Drug Targets CNS Neurol Disord 2005;4:223-233.
59. Granberry MC, Fonseca VA: Insulin resistance syndrome: options for treatment. South Med J 1999;92:2-15.
60. Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN: Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994;17:30-36.